Research identifies cannabidiol (CBD) as a promising and sustainable alternative for controlling viral diseases in aquaculture, replacing the use of antibiotics

Scientific survey indicates that cannabidiol may interfere with mechanisms related to the progression and spread of tumors in different types of cancer

Clinical study suggests that cannabidiol may help reduce emotional symptoms linked to the menstrual cycle, such as anxiety, irritability, and stress

Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS

Brazilian study reveals that cannabidiol can relieve pain, seizures, and inflammations in dogs, opening new perspectives for veterinary medicine

Agreement between regulatory agency and veterinary institute evaluates the use of cannabidiol as an alternative to antibiotics in poultry farming

Pharmaceutical company Farmausa Life Science has obtained registration for its Cannabidiol in two concentrations, 20 mg/mL and 100 mg/mL, with low THC content

Favorable decision to Biomagistral network allows the production of formulations with Cannabidiol under prescription

Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution

Still in the study phase, cannabidiol shows potential to relieve symptoms such as pain, swelling, and insomnia related to varicose veins

City Hall evaluates the implementation of a public policy to provide cannabidiol-based medications in the municipality

Report shows that nearly 400 million people worldwide have alcohol-related disorders. Scientists are investigating cannabidiol (CBD) as a promising tool in combating addiction

Research indicates that chronic use of nicotine pouches worsens seizures and brain inflammation, conditions mitigated by inhaled CBD administration

New FDA study shows that CBD can cause liver damage in some people. Understand the risks, symptoms, and what to do to use it safely

Compounds like CBN, CBC, and CBG are gaining prominence in science for their distinct therapeutic properties and role in the entourage effect

Judicial decisions, legislative changes, and inquiries in the European Union keep the sector on hold in the country

Check out Sechat's glossary

Interim decision ensures the commercialization of oils and extracts until May 2026 and prevents economic losses to the sector

Analysis of over 47,000 animals indicates that prolonged use of CBD is associated with positive changes in canine behavior

Badger G® variety promises to boost the pharmaceutical sector and facilitate monitoring with red leaves and high CBG content